Showing results (441-450 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|May 17, 2022
Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive DisorderYuki Shigetsura, Satoshi Imai, Hiroki Endo, et al.Clinical Neuropharmacology|May 17, 2022
The Effect of Rotigotine on Cognitive Function, Daytime Sleepiness, and Sleep Problems in Parkinson Disease: An Open-Label Pilot StudyKeisuke Suzuki, Kei Funakoshi, Hiroaki Fujita, et al.Clinical Neuropharmacology|December 1, 1987
Benzodiazepine withdrawal seizures: analysis of 48 case reportsJ Fialip, O Aumaitre, A Eschalier, et al.Clinical Neuropharmacology|October 13, 2009
Akinetic mutism induced by tacrolimusFernando Sierra-Hidalgo, Antonio Martínez-Salio, Sara Moreno-García, et al.Clinical Neuropharmacology|October 13, 2009
Can quetiapine-induced hypothyroidism be reversible without quetiapine discontinuation?Vassilis P Kontaxakis, Dimitris Karaiskos, Beata J Havaki-Kontaxaki, et al.Clinical Neuropharmacology|January 15, 2021
Severe Relapses of Neuromyelitis Optica Spectrum Disorder During Treatment With Dimethyl FumarateNina Javadian, Hana Magrouni, Majid Ghaffarpour, et al.Clinical Neuropharmacology|February 1, 1988
Continuous duodenal infusions of levodopa: plasma concentrations and motor fluctuations in Parkinson's diseaseJ I Sage, L Schuh, R E Heikkila, et al.Clinical Neuropharmacology|December 1, 1988
Failure of high-dose intravenous magnesium sulfate to control myoclonic status epilepticusR S Fisher, P W Kaplan, A Krumholz, et al.Clinical Neuropharmacology|February 9, 2021
Subcortical Structure Disruption in Diffusion Tensor Tractography of the Patient With the Syndrome of Irreversible Lithium-Effectuated Neurotoxicity Combined With Neuroleptic Malignant Syndrome: A Case ReportSeung Yeon Rhee, Hyoung Seop KimClinical Neuropharmacology|December 13, 2016
Alcohol-Sensitive Generalized DystoniaFederico Micheli, Claudia Uribe-Roca, Michel Saenz-FarretPageof 236